Insilico Generative Biologics

What it does

Insilico Generative Biologics takes in target information and existing binder data, including your own project data for model training, and produces candidate biologics such as peptides, nanobodies, and antibodies. The page describes de novo binder generation for hard targets and specific epitopes, template-based generation of improved 3D variants, and prediction of affinity and developability properties.

Teams use it in a discovery workflow: generate binder candidates, predict their properties early, then run an optimization workflow that balances affinity and developability at the same time. The page says it combines over 10 generative and predictive models with physics-based tools, and that users can train project-specific predictive models on their own data. It also states binder candidates can be generated in less than 24 hours.

It suits drug discovery teams working on biologics who want AI-assisted design and property prediction. Access is not self-serve: the page directs readers to 'Contact us' or 'Schedule a Call' and describes flexible business models, either standalone technology access or combined with Pharma.ai collaborations. The page does not state pricing, supported input or output file formats, or integrations, and it notes that clinical trial or treatment questions should go to a healthcare provider.

What it can do

• De novo binder generation for hard targets and desired epitopes
• Template-based generation of novel improved binder variants in 3D
• Multi-property optimization balancing affinity and developability
• Training project-specific predictive models on your own data
• Built-in pre-trained models for developability property prediction
• Candidate selection by desired properties for further development

Before you choose

• Pricing and terms are not published; engagement is arranged through sales contact.
• The page does not specify supported input or output formats or external integrations.
• Generated candidates are for discovery research; the page does not establish clinical use.

Listed under

• Data
• Research

Get started

Use 'Contact us' or 'Schedule a Call' on the product page.

1. Contact Insilico Medicine via the 'Contact us' or 'Schedule a Call' option on the product page.
2. Choose a business model: stand-alone technology access or combined with Pharma.ai collaborations.
3. Define target proteins or epitopes and, if desired, provide your own data to train project-specific predictive models.

The page mentions 'Flexible Business Models' with standalone technology access or combined Pharma.ai collaborations, but no prices, units, or billing intervals are stated.

We couldn’t find published prices for Insilico Generative Biologics.

Sources for this overview

Product pages, documentation, and pricing checked 29 Oct 2026. Each source supports part of the overview; availability and prices can change.

• Biology42: Generative Biologics ↗pharma.ai
• Main | Insilico Medicine ↗insilico.com

Company website

pharma.ai: product, pricing and policy pages

Web search

Confirms the official site

Social accounts

Accounts the company links, and its posts on X

Human review

Checked by a person

knowledge_base

manual_review

Last checked 29 Oct 2026. Every field keeps its source and date; unknown means we couldn’t confirm it.